Intrathecal Delivery of Recombinant Adeno-Associated Virus 9
AssigneesNationwide Children's Hospital, Inc., Ohio State Innovation Foundation
InventorsBrian K. Kaspar, Arthur Burghes, Paul Porensky
Life of this patent
Estimating the term…
Abstract
The present invention relates to Adeno-associated virus type 9 methods and materials useful for intrathecal delivery of polynucleotides. Use of the methods and materials is indicated. for example. for treatment of lower motor neuron diseases such as SMA and ALS as well as Pompe disease and lysosomal storage disorders.
Claims18
A method of delivering a polynucleotide to the central nervous system of a patient in need thereof comprising intrathecal delivery of a rAAV9 and a non-ionic, low-osmolar contrast agent to the patient, wherein the rAAV9 comprises a self-complementary genome including the polynucleotide.
A method of treating a lysosomal storage disorder in a patient in need thereof comprising intrathecal delivery of a rAAV9 and a non-ionic, low-osmolar contrast agent to the patient, wherein the rAAV9 comprises a self-complementary genome including a therapeutic polynucleotide.
Dependencies are inferred from the claim text.